| Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded … A Svenningsson, T Frisell, J Burman, J Salzer, K Fink, S Hallberg, ... The Lancet Neurology 21 (8), 693-703, 2022 | 62 | 2022 |
| Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: a real‐world investigation I Rosenstein, S Rasch, M Axelsson, L Novakova, K Blennow, H Zetterberg, ... Journal of neurochemistry 159 (3), 618-628, 2021 | 32 | 2021 |
| Exploring CSF neurofilament light as a biomarker for MS in clinical practice; a retrospective registry-based study I Rosenstein, M Axelsson, L Novakova, K Blennow, H Zetterberg, J Lycke Multiple Sclerosis Journal 28 (6), 872-884, 2022 | 17 | 2022 |
| High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis I Rosenstein, M Axelsson, L Novakova, S Rasch, K Blennow, H Zetterberg, ... Frontiers in immunology 14, 1106028, 2023 | 9 | 2023 |
| Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing–remitting multiple sclerosis I Rosenstein, M Axelsson, L Novakova, C Malmeström, K Blennow, ... Journal of Neurology 270 (10), 4800-4811, 2023 | 7 | 2023 |
| Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis N Fissolo, P Benkert, J Sastre-Garriga, N Mongay-Ochoa, ... Journal of Neurology, Neurosurgery & Psychiatry 95 (5), 410-418, 2024 | 4 | 2024 |
| Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis I Rosenstein, S Rasch, M Axelsson, L Novakova, K Blennow, H Zetterberg, ... Frontiers in immunology 13, 967953, 2022 | 4 | 2022 |
| Cerebrospinal fluid sulfatide isoforms lack diagnostic utility in separating progressive from relapsing-remitting multiple sclerosis L Novakova, M Henricsson, E Björnson, M Axelsson, J Borén, ... Multiple sclerosis and related disorders 74, 104705, 2023 | 3 | 2023 |
| Four Swedish cases of CSF1R‐related leukoencephalopathy: Visualization of clinical phenotypes I Rosenstein, O Andersen, D Victor, E Englund, T Granberg, ... Acta Neurologica Scandinavica 145 (5), 599-609, 2022 | 3 | 2022 |
| Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study M Johnsson, YT Stenberg, HH Farman, K Blennow, H Zetterberg, ... Multiple Sclerosis Journal 30 (6), 664-673, 2024 | 2 | 2024 |
| Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis–a multicentre study H Hegen, K Berek, P Cavalla, M Christiansen, A Emeršič, M Di Filippo, ... Frontiers in immunology 14, 1327947, 2023 | 1 | 2023 |
| Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis I Rosenstein, A Nordin, H Sabir, C Malmeström, K Blennow, M Axelsson, ... Journal of Neurology, 1-11, 2024 | | 2024 |
| IgG and kappa free light chain CSF/serum indices: evaluating intrathecal immunoglobulin production in HIV infection in comparison with multiple sclerosis L Hagberg, I Rosenstein, J Lycke, H Zetterberg, A Yilmaz, A Edén, ... Clinical Chemistry and Laboratory Medicine (CCLM), 2024 | | 2024 |
| Baseline serum glial fibrillary acidic protein levels associate with progression independent of relapse activity in relapsing-remitting multiple sclerosis I Rosenstein, M Axelsson, C Malmestrom, S Sandgren, J Lycke, ... MULTIPLE SCLEROSIS JOURNAL 29, 575-576, 2023 | | 2023 |
| Prognostic biomarkers in NMOSD K Eriksson, M Axelsson, M Johnsson, J Lycke, LN Nyren, I Rosenstein, ... MULTIPLE SCLEROSIS JOURNAL 29, 668-668, 2023 | | 2023 |
| Diagnostic performance of Kappa Free Light Chain Index in Patients with Primary Progressive Multiple Sclerosis-a multicentre study K Berek, P Cavalla, M Christiansen, A Emersic, M Di Filippo, L Gaetani, ... MULTIPLE SCLEROSIS JOURNAL 29, 568-569, 2023 | | 2023 |
| Diagnostic, Prognostic, and Disease Activity Biomarkers in Multiple Sclerosis I Rosenstein | | 2023 |
| Increased intrathecal neurofilament light and IgM predict severe disability in relapsing-remitting multiple sclerosis I Rosenstein, S Rasch, M Axelsson, L Novakova, K Blennow, H Zetterberg, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 308-309, 2022 | | 2022 |
| CSF1R-Related Leukoencephalopathy Caused by CSF1R p. Arg777Trp and CSF1R p. Arg782Cys Mutations: A Report of Four Cases in Sweden I Rosenstein, O Andersen, V Daniel, E Englund, T Granberg, ... | | 2021 |
| Hereditary Diffuse Leukoencephalopathy with Spheroids caused by R777W and R782C mutations in CSF1R: A report of four cases in Sweden (2017) I Rosenstein, O Andersen, E Englund, T Granberg, K Jood, YA Fitrah, ... Neurology 96 (15 Supplement), 2021 | | 2021 |
